bullish
Venus Medtech (启明医疗) & Peijia Medical (沛嘉医疗) Placement - Take Your Pick
373 Views21 Jan 2021 18:57
Venus MedTech (2500 HK) is looking to raise up to US$187m in its primary placement. At the same time, Peijia Medical (9996 HK) is looking to raise about US$104m.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Zhen Zhou, Toh
APAC IPOs & Placements
- MicroPort CardioFlow: What You Have to Assume27 Jan 2021
- MicroPort CardioFlow: PHIP Updates and More on TMV21 Jan 2021
- Venus Medtech (启明医疗) & Peijia Medical (沛嘉医疗) Placement - Take Your Pick21 Jan 2021
- Microport Cardioflow: Winning in TAVR10 Jan 2021
- Pre-IPO MicroPort CardioFlow - A Better Candidate of the TAVR Market in China?16 Dec 2020
- Venus Medtech (启明医疗) Placement - Already Has Ample Cash but Doesn't Hurt to Have More for R&D02 Sep 2020
x